Skip to content

Insulet PODD Operating Income

Operating Income at other companies

Medtronic logo
MedtronicMDT
$1.87B+30.4%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$177.1M+65.5%
Abbott logo
AbbottABT
$1.35B-20.6%
Viatris logo
ViatrisVTRS
-$79.7M+97.2%

Other financials

Income statement

See full
Revenue$761.7M+33.9%
Gross profit$529.0M+29.3%
Net income$91.1M+157%
EPS (diluted)$1.30+160%

Balance sheet

See full
Cash & equivalents$480.4M-62.6%
Total debt$969.7M-45.5%
Total equity$1.3B-2.1%
Total assets$3.0B-15.1%

Cash flow

See full
Operating cash flow$113.8M+78.4%
CapEx$24.3M+97.6%
Free cash flow$89.5M+73.8%

Valuation

See full
Market cap$10.1B-19.9%
Enterprise value$10.59B-19.4%
P/E33.3×+2.0×
P/S3.5×-2.3×

Profitability

See full
Gross margin71%+0.6pp
Operating margin17.5%+2.0pp
Net margin10.4%-7.9pp
FCF margin14.3%+1.1pp

Returns & leverage

See full
Return on equity23%-14.9pp
Debt / equity0.7×-0.6×
Current ratio2.5×-2.0×

Where this comes from

Reported directly by Insulet in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Insulet’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insulet's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Insulet's operating income?
Insulet (PODD) reported operating income of $122.1M in Q1 2026.
How has Insulet's operating income changed year-over-year?
Insulet's operating income increased by 37.5% year-over-year, from $88.8M to $122.1M.
What is the long-term trend for Insulet's operating income?
Over 4 years (2021 to 2025), Insulet's operating income has grown at a 39.3% compound annual growth rate (CAGR), from $126M to $473.9M.
What does operating income mean?
Profit earned from core business operations before interest and taxes.
How do you interpret operating income?
An increase indicates improved operational efficiency and profitability, while a decrease signals rising costs or declining sales.
How does operating income compare across companies?
Used universally to compare the operational efficiency of companies regardless of their capital structure.